Publisher's report Generics: BRIC (Brazil, Russia, India,China) Industry Guide provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The guide also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the generics industry and had a total market value of $86.7 billion in 2015. China was the fastest growing country with a CAGR of 18.3% over the 2011-15 period.

Within the generics industry, China is the leading country among the BRIC nations with market revenues of $56.6 billion in 2015. This was followed by India, Russia and Brazil with a value of $13.1, $10.0, and $6.9 billion, respectively. China is expected to lead the generics industry in the BRIC nations with a value of $114.8 billion in 2020, followed by India, Russia, Brazil with expected values of $32.3, $15.9 and $8.8 billion, respectively.

Scope of the report includes:

• What was the size of the BRIC generics market by value in 2015
  
• What will be the size of the BRIC generics market in 2020
  
• What factors are affecting the strength of competition in the BRIC generics market
  
• How has the market performed over the last five years
  
• How large is the BRIC generics market in relation to its regional counterparts